Literature DB >> 24797165

Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL/6J mice treated with D-galactose.

T-Y Song1, H-C Lin, C-L Chen, J-H Wu, J-W Liao, M-L Hu.   

Abstract

Male C57BL/6J mice treated with D-galactose (DG) were used to examine the effects of ergothioneine (EGT), melatonin (MEL), or their combination (EGT+MEL) on learning and memory abilities. The mice were divided into five groups and injected subcutaneously with DG (0.3 mL of 1% DG/mouse) except for group 1 (normal controls). Group 3 was orally supplemented with EGT [0.5 mg/kg body weight (bw)], group 4 with MEL (10 mg/kg bw, p.o.), and group 5 with EGT+MEL. EGT and MEL were provided daily for 88 days, while DG was provided between days 7 to 56. Active avoidance task and Morris water-maze task were used to evaluate learning and memory abilities. DG treatment markedly increased escape latency and decreased the number of avoidance in the active avoidance test, whereas EGT and MEL alone significantly improved the performance. DG also impaired the learning and memory abilities in the water-maze task, and EGT and MEL alone also significantly improved the performance. EGT+MEL produced the strongest effects in both tasks. EGT and MEL alone markedly decreased β-amyloid protein accumulation in the hippocampus and significantly inhibited lipid peroxidation and maintained glutathione/glutathione disulfide ratio and superoxide dismutase activity in brain tissues of DG-treated mice. MEL alone completely prevented the rise in brain acetylcholine esterase activity induced by DG, whereas EGT and EGT+MEL were only partially effective. Overall, EGT, MEL, and, in particular, the combination of EGT and MEL effectively protect against learning and memory deficits in C57BL/6J mice treated with DG, possibly through attenuation of oxidative damage.

Entities:  

Keywords:  Alzheimer's disease; D-galactose; ergothioneine; learning and memory; melatonin

Mesh:

Substances:

Year:  2014        PMID: 24797165     DOI: 10.3109/10715762.2014.920954

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  10 in total

Review 1.  Ergothioneine and central nervous system diseases.

Authors:  Noritaka Nakamichi; Sota Tsuzuku; Fumiya Shibagaki
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

Review 2.  Ergothioneine: A Stress Vitamin with Antiaging, Vascular, and Neuroprotective Roles?

Authors:  Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2021-12-07       Impact factor: 7.468

3.  Protective Effect of Ergothioneine Against Stroke in Rodent Models.

Authors:  Wei-Yi Ong; Mei-Han Kao; Wai-Mui Cheung; Damien Meng-Kiat Leow; Irwin Kee-Mun Cheah; Teng-Nan Lin
Journal:  Neuromolecular Med       Date:  2022-10-19       Impact factor: 4.103

4.  Protective Effects and Possible Mechanisms of Ergothioneine and Hispidin against Methylglyoxal-Induced Injuries in Rat Pheochromocytoma Cells.

Authors:  Tuzz-Ying Song; Nae-Cherng Yang; Chien-Lin Chen; Thuy Lan Vo Thi
Journal:  Oxid Med Cell Longev       Date:  2017-10-17       Impact factor: 6.543

5.  Engineering the Yeast Saccharomyces cerevisiae for the Production of L-(+)-Ergothioneine.

Authors:  Steven A van der Hoek; Behrooz Darbani; Karolina E Zugaj; Bala Krishna Prabhala; Mathias Bernfried Biron; Milica Randelovic; Jacqueline B Medina; Douglas B Kell; Irina Borodina
Journal:  Front Bioeng Biotechnol       Date:  2019-10-11

6.  The biology of ergothioneine, an antioxidant nutraceutical.

Authors:  Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell
Journal:  Nutr Res Rev       Date:  2020-02-13       Impact factor: 7.800

7.  A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications.

Authors:  William J Behof; Clayton A Whitmore; Justin R Haynes; Adam J Rosenberg; Mohammed N Tantawy; Todd E Peterson; Fiona E Harrison; Robert B Beelman; Wellington Pham
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

8.  Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer's Disease.

Authors:  Clayton A Whitmore; Justin R Haynes; William J Behof; Adam J Rosenberg; Mohammed N Tantawy; Brian C Hachey; Brian E Wadzinski; Benjamin W Spiller; Todd E Peterson; Krista C Paffenroth; Fiona E Harrison; Robert B Beelman; Printha Wijesinghe; Joanne A Matsubara; Wellington Pham
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-13

9.  Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging.

Authors:  Elisa Roda; Erica Cecilia Priori; Daniela Ratto; Fabrizio De Luca; Carmine Di Iorio; Paola Angelone; Carlo Alessandro Locatelli; Anthea Desiderio; Lorenzo Goppa; Elena Savino; Maria Grazia Bottone; Paola Rossi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

10.  Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances.

Authors:  Yoshiki Matsuda; Nobuyuki Ozawa; Takiko Shinozaki; Ken-Ichi Wakabayashi; Kosuke Suzuki; Yusuke Kawano; Iwao Ohtsu; Yoshitaka Tatebayashi
Journal:  Transl Psychiatry       Date:  2020-05-28       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.